Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Panel Reactive Antibodies”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Post-approval studies (Phase 4)Study completedNCT00784979
What this trial is testing

Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation

Who this might be right for
End Stage Renal Disease
Tampa General Hospital 26
Early research (Phase 1)Study completedNCT00143741
What this trial is testing

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Who this might be right for
End-Stage Kidney Disease
University of Chicago 20
Large-scale testing (Phase 3)Study completedNCT00693576
What this trial is testing

The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates

Who this might be right for
Renal Transplantation
Shiraz University of Medical Sciences 82
Testing effectiveness (Phase 2)WithdrawnNCT03593421
What this trial is testing

Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies

Who this might be right for
Panel Reactive Antibodies
Christopher O'Brien, MD
Not applicableStudy completedNCT00407160
What this trial is testing

A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients

Who this might be right for
Kidney Diseases
The University of Texas Medical Branch, Galveston 21
Not applicableEnded earlyNCT01334281
What this trial is testing

An In-vitro Standardization of B Cell Elispot Assays

Who this might be right for
Transplant SensitizationPanel Reactive AntibodySensitization to HLA Antigens
Northwestern University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36
Not applicableStudy completedNCT01135485
What this trial is testing

Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart Syndrome

Who this might be right for
Congenital Heart Disease
University of Pennsylvania 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05017545
What this trial is testing

Carfilzomib and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 21